18
Mar
2026
Putting stem cell treatments into an insurance model castrates patient decision-making.
And the second you put this in an insurance model or a government payer model, everybody is castrated. The decisions are made at the insurance level and at the government level, and it just becomes this nuanced, challenging thing.